SCHEMBL10110596

SCHEMBL10110596

CC[C@H]1NC(=O)N[C@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL497854 1.00
SCHEMBL6269532 0.84 TDP1 (0.36)
SCHEMBL14026498 0.78
SCHEMBL12663905 0.78
SCHEMBL13448397 0.75 TDP1 (0.44)
SCHEMBL20123222 0.75 TDP1 (0.44)
SCHEMBL13448308 0.75 TDP1 (0.44)
SCHEMBL6561453 0.74 ABL1 (0.65)
SCHEMBL3384844 0.74
SCHEMBL6036786 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190330693-A1 SINGLE FLUORESCENT DYE-BASED SEQUENCING METHOD Qingdao MGI Tech Co., Ltd. (CN) 2019-10-31 US disclosed
US-20180127822-A1 MODIFIED NUCLEOTIDES METHODS AND KITS PIERCE BIOTECHNOLOGY, INC. (US) 2018-05-10 US disclosed
EP-2203161-B1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF UNIV INDIANA RES & TECH CORP (US) 2018-05-09 EP disclosed
US-9828633-B1 Modified nucleotides methods and kits PIERCE BIOTECHNOLOGY, INC. (US) 2017-11-28 US disclosed
US-20120157403-A1 BICYCLIC AND TRICYCLIC DERIVATIVES AS THROMBIN RECEPTOR ANTAGONISTS CHACKALAMANNIL SAMUEL (US) 2012-06-21 US disclosed
US-20080090830-A1 Bicyclic And Tricyclic Derivatives As Thrombin Receptor Antagonists SCHERING CORPORATION 2008-04-17 US disclosed